Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Envoy Medical, Inc. - Class A Common Stock (NQ:COCH)

0.6230 +0.0130 (+2.13%)
Streaming Delayed Price Updated: 9:30 AM EDT, Apr 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,944
Open 0.6100
Bid (Size) 0.6100 (900)
Ask (Size) 0.6359 (200)
Prev. Close 0.6100
Today's Range 0.6100 - 0.6230
52wk Range 0.3625 - 1.910
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant
White Bear Lake, Minnesota--(Newsfile Corp. - April 1, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company... 
Via Newsfile
News headline image
Envoy Medical Reports Full Year 2025 Financial Results
Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing... 
Via Newsfile
Topics Intellectual Property

Performance

YTD
-10.4%
-10.4%
1 Month
-21.2%
-21.2%
3 Month
-12.5%
-12.5%
6 Month
-30.7%
-30.7%
1 Year
-54.2%
-54.2%

More News

Read More
News headline image
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant
Via Newsfile
News headline image
Envoy Medical Regains Compliance with Nasdaq Listing Requirement
Via Newsfile
News headline image
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space
Via Newsfile
Topics Intellectual Property
News headline image
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial
Via Newsfile
News headline image
Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
Via Newsfile
News headline image
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering
Via Newsfile
These stocks have an unusual volume in today's session ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
Which stocks are experiencing notable movement on Wednesday? ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
News headline image
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering
Via Newsfile
News headline image
Small Cap Growth Virtual Investor Conference: Presentations Now Available for On-Demand Viewing
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Small Cap Growth Virtual Investor Conference Agenda Announced for February 5th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
Via Newsfile
News headline image
Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio
Via Newsfile
Topics Intellectual Property
News headline image
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant
Via Newsfile
News headline image
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient
Via Newsfile
News headline image
Envoy Medical Announces the Grant of Its 40th U.S. Patent
Via Newsfile
Topics Intellectual Property
News headline image
Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery
Via Newsfile
Topics Intellectual Property
News headline image
Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial
Via Newsfile
Topics Intellectual Property
News headline image
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
Via Newsfile
Topics Intellectual Property
News headline image
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial
Via Newsfile

Frequently Asked Questions

Is Envoy Medical, Inc. - Class A Common Stock publicly traded?
Yes, Envoy Medical, Inc. - Class A Common Stock is publicly traded.
What exchange does Envoy Medical, Inc. - Class A Common Stock trade on?
Envoy Medical, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Envoy Medical, Inc. - Class A Common Stock?
The ticker symbol for Envoy Medical, Inc. - Class A Common Stock is COCH on the Nasdaq Stock Market
What is the current price of Envoy Medical, Inc. - Class A Common Stock?
The current price of Envoy Medical, Inc. - Class A Common Stock is 0.6230
When was Envoy Medical, Inc. - Class A Common Stock last traded?
The last trade of Envoy Medical, Inc. - Class A Common Stock was at 04/13/26 09:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.